RZLT has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
RZLT has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Debt-to-EBITDA measures a company's ability to pay off its debt.
Rezolute's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $0.54 Mil. Rezolute's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $1.98 Mil. Rezolute's annualized EBITDA for the quarter that ended in Dec. 2023 was $-60.74 Mil. Rezolute's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was -0.04.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's
The historical rank and industry rank for Rezolute's Debt-to-EBITDA or its related term are showing as below:
The historical data trend for Rezolute's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Rezolute's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Biotechnology industry and Healthcare sector, Rezolute's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Rezolute's Debt-to-EBITDA falls into.
Debt-to-EBITDA measures a company's ability to pay off its debt.
Rezolute's Debt-to-EBITDA for the fiscal year that ended in Jun. 2023 is calculated as
Debt-to-EBITDA | = | Total Debt | / | EBITDA | ||
= | (Short-Term Debt & Capital Lease Obligation | + | Long-Term Debt & Capital Lease Obligation) | / | EBITDA | |
= | (0.541 | + | 1.937) | / | -51.757 | |
= | -0.05 |
Rezolute's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as
Debt-to-EBITDA | = | Total Debt | / | EBITDA | ||
= | (Short-Term Debt & Capital Lease Obligation | + | Long-Term Debt & Capital Lease Obligation) | / | EBITDA | |
= | (0.538 | + | 1.975) | / | -60.736 | |
= | -0.04 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Dec. 2023) EBITDA data.
Rezolute (NAS:RZLT) Debt-to-EBITDA Explanation
In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.
Be Aware
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's
Thank you for viewing the detailed overview of Rezolute's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Brian Kenneth Roberts | officer: Chief Medical Officer | C/O REZOLUTE, INC., 201 REDWOOD SHORES PARKWAY, SUITE 315, REDWOOD CITY CA 94065 |
Gil M Labrucherie | director | 150 INDUSTRIAL ROAD, SAN CARLOS CA 94070 |
Wladimir Hogenhuis | director | 60 LEVERONI COURT, NOVATO CA 94949 |
Nerissa Kreher | director | C/O AVROBIO, INC., ONE KENDALL SQ., BLDG. 300, STE. 201, CAMBRIDGE MA 02139 |
Handok, Inc. | 10 percent owner | 132, TEHERAN-RO, GANGNAM GU, SOUL M5 06235 |
Philippe Fauchet | director | C/O REZOLUTE, INC., 201 REDWOOD SHORES PARKWAY, SUITE 315, REDWOOD CITY CA 94065 |
Junghee Lim | director | C/O REZOLUTE, INC., 201 REDWOOD SHORE'S PARKWAY, SUITE 315, REDWOOD CITY CA 94065 |
Genexine Inc. | 10 percent owner | 700 DAEWANGPANGYO-RO, KOREA PARKBLDG. B, BUNDANG-GU, SEONGNAM-SI, GYEONGGI-DO M5 13488 |
Seline E. Miller | officer: VP Finance & CAO | C/O REZOLUTE, INC., 1450 INFINITE DRIVE, LOUISVILLE CO 80027 |
Young-jin Kim | director | 49, BONGEUNSA-RO 49-GIL, GANGNAM-GU, SEOUL M5 06100 |
Young Chul Sung | director | 101DONG 404HO, PARKTOWER APT. 69, SEOBINGGO-RO, YONGSAN-GU, SEOUL M5 04385 |
Keith A. Vendola | officer: Chief Financial Officer | 111 LIVORNO WAY, REDWOOD CITY CA 94065 |
Xoma Corp | 10 percent owner | 2200 POWELL STREET, SUITE 310, EMERYVILLE CA 94608 |
David F Welch | director | C/O INFINERA CORPORATION, 140 CASPIAN COURT, SUNNYVALE CA 94089 |
Morgan Fields | officer: Chief Accounting Officer | 890 SANTA CRUZ AVE., MENLO PARK CA 94025 |
From GuruFocus
By GuruFocusNews GuruFocusNews • 06-01-2022
By Value_Insider Value_Insider • 10-20-2022
By GuruFocusNews GuruFocusNews • 05-12-2022
By Marketwired • 09-14-2023
By GuruFocusNews GuruFocusNews • 05-04-2022
By Marketwired • 10-17-2023
By PurpleRose PurpleRose • 07-11-2022
By GlobeNewswire GlobeNewswire • 05-01-2022
By PurpleRose PurpleRose • 07-11-2022
By Marketwired • 10-11-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.